EPISODE · Apr 30, 2026 · 23 MIN
MASLD & The FIB-4 Fast-Track: 2026 Guidelines for the Australian GP
from Synapse: The Australian GP Studycast · host Mukul Modgil
Send us Fan MailSteatotic Liver Disease affects roughly 30% of adult Australians. Are you screening correctly? This episode is a practical guide for the frontline GP. We discuss how to pivot your consults from a "diagnosis of exclusion" to a "positive diagnosis" based on cardiometabolic risk factors. Nomenclature Shift: Why we stopped saying "Non-Alcoholic" and "Fatty."Workup: Using ultrasound as a first-line tool and the serum markers that actually matter. Stigma & Communication: How to explain MASLD to your patients without the "blame" associated with previous terminology.2026 Updates: A look at the latest PBS-listed supports and the GP's role in long-term surveillance.Support the show⚠️ Disclaimer: The voices in this podcast are AI-generated. This content is produced for entertainment and learning purposes only and does not constitute medical advice. Clinical decisions should always be made in accordance with current guidelines, individual patient circumstances, and in consultation with appropriate colleagues and specialists.
Embed this episode
What this episode covers
Send us Fan Mail Steatotic Liver Disease affects roughly 30% of adult Australians. Are you screening correctly? This episode is a practical guide for the frontline GP. We discuss how to pivot your consults from a "diagnosis of exclusion" to a "positive diagnosis" based on cardiometabolic risk factors. Nomenclature Shift: Why we stopped saying "Non-Alcoholic" and "Fatty."Workup: Using ultrasound as a first-line tool and the serum markers that actually matter. Stigma & Communicat...
NOW PLAYING
MASLD & The FIB-4 Fast-Track: 2026 Guidelines for the Australian GP
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.